Where does Abb Vie Deutschland Gmbh & Co. KG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abb Vie Deutschland Gmbh & Co. KG ranks #3,004 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abb Vie Deutschland Gmbh & Co. KG hold?

Abb Vie Deutschland Gmbh & Co. KG holds 126 US utility patents granted between 2015 and 2025, spanning 25 technology areas.

What is Abb Vie Deutschland Gmbh & Co. KG's Innovation Score?

Abb Vie Deutschland Gmbh & Co. KG has an Innovation Score of 50.4 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abb Vie Deutschland Gmbh & Co. KG focus on?

Abb Vie Deutschland Gmbh & Co. KG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 104 patents, ranking #147 of 6,058 assignees active in that subclass. Grants appear in 25 CPC subclasses total.

Is Abb Vie Deutschland Gmbh & Co. KG's patent grant rate increasing or decreasing?

Abb Vie Deutschland Gmbh & Co. KG's recent grant velocity is -89% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abb Vie Deutschland Gmbh & Co. KG's patents?

Abb Vie Deutschland Gmbh & Co. KG's patents average 21.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abb Vie Deutschland Gmbh & Co. KG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abb Vie Deutschland Gmbh & Co. KG

USPTO PatentsView assignee record - 126 granted patents across 25 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abb ranks #3,004 of 49,997 tracked US assignees by granted-patent volume, with 126 patents across 25 technology areas.

#3,004
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.4/100): 21.0
avg claims per patent: -89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3004 · Foreign Corporation #3,004 · 126 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 126 grants
TOP-DECILE #3,004/49,997
PHOTO-FINISH Ceres
CPC-FOCUS A61P · 25 areas
INNOV-PAR 50.4/100
CLAIMS-DENSE 21.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -89% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ceres, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abb’s 50.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.7 pts (33%) Velocity 3.3 pts (7%) Breadth 17.7 pts (35%) Claim depth 12.6 pts (25%)

Qualcomm Incorporated · highest

85
Zhongshan Broad-ocea… · near

50
Abb Vie Deutschland… · this assignee

50
Bemis Associates · near

50
Ferro · near

50
Jiaxing Super… · near

50
3D Lighting… · lowest

7

What this shows Abb's Innovation Score is 50.4/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abb?

Each dot is one of Abb’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abb’s own 21.0 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abb vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abb's grants concentrate

Abb Vie Deutschland Gmbh & Co. KG is a focused PatentsView assignee: 25 CPC subclasses with 82.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (35 grants) versus a trough of 2 in 2024. By volume, Abb sits between W. Kordes' SÖHNE Rosenschulen GmbH & Co KG and Dexin Corporation.

Abb's three-year grant acceleration

Abb Vie Deutschland Gmbh & Co. KG shows 6 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

W Kordes' SÖHNE R…

127
Wangsu Science AN…

127
Whitehead Institu…

127
Wyeth

127
Chatsworth Produc…

126
Ceres

126
Cobra Golf Incorp…

126
Dexin

126
Abb Vie Deutschla… ◀

126

What this shows Abb holds 126 patents at rank #3,004, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abb

By rank, the assignees closest to #3,004 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Abb's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abb, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Abb ranks #147 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Jiaxing Super Lighting Electric Appliance Co., Ltd 50 Bemis Associates, Inc. 50 Ferro Corporation 50 Zhongshan Broad-ocean Motor Co., Ltd. 50

Similar claim depth

Nearest assignees by average claims per patent (21.0 here).

Resonant Inc. 21.0 avg Packsize, LLC 21.0 avg Hypertherm, Inc. 21.0 avg Muffin Incorporated 21.0 avg

Abb's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abb Vie Deutschland Gmbh & Co. KG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	35	27.8%
2016	32	25.4%
2017	24	19.0%
2018	15	11.9%
2019	6	4.8%
2020	6	4.8%
2022	4	3.2%
2024	2	1.6%
2025partial year	2	1.6%

Which technologies does Abb Vie Deutschland Gmbh & Co. KG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 104

C07D - Heterocyclic Compounds 75

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 63

C07K - Peptides 32

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 21

C07C - Acyclic OR Carbocyclic Compounds 9

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 7

Y02A - Technologies FOR Adaptation TO Climate Change 6

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 3

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

Top 15 of 25 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abb Vie Deutschland Gmbh & Co. KG's patent record in context - here's where to go next.

Abb Vie Deutschland Gmbh & Co. KG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 82.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,004 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abb Vie Deutschland Gmbh & Co. KG against W. Kordes' SÖHNE Rosenschulen GmbH & Co KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.